Healthcare’s latest Innovations - 12th Edition

Dear subscriber,

Welcome back to our 12th edition, where we will explore the following topics:

Industry Insights:

1. The use of patient data to support Launch Excellence
2. Unlocking better business Outcomes with the Nominative Pharmacy Tracker

Thought Leadership:

1. Key Updates and Benefits from our Information Offerings
2. Transforming Belgium into a Leader in Real-World Data Evidence Generation: 10 Recommendations for a Data-Driven Healthcare System

The use of patient data to support Launch Excellence

Launching a new pharmaceutical product requires meticulous planning, strategic foresight, and adaptability. The success of a medication launch impacts patients awaiting innovative treatments, especially in a constantly evolving healthcare landscape. Cross-functional team collaboration is crucial, with medical professionals playing a pivotal role in bridging clinical insights and strategic execution.

Real-world data (RWD) is essential for understanding patient journeys, care pathways, and market dynamics. IQVIA leverages advanced analytics and machine learning to provide actionable insights, helping identify the right patients and physicians. Our longitudinal metrics on prescribers, patients, and dispensed products offer detailed tracking and analysis.

Advanced targeting, adherence analysis, and patient tracking are key features that support successful launches and sustained performance. For more information, contact Deborah Alberts at [email protected].

Unlocking better business Outcomes with the Nominative Pharmacy Tracker

Introducing the Nominative Pharmacy Tracker, a powerful tool designed to enhance your understanding of pharmacy sales performance and optimize commercial strategies. Key features include detailed sales tracking by product, category, region, and time, strengthening pharmacy partnerships through data-driven insights, and hypercare tracking for new product launches with weekly updates and monthly reports. The tracker also offers campaign analysis to measure promotional impact, commercial policy alignment with market trends, and engagement insights linking sales performance to pharmacy interactions.

Seamlessly integrating with existing systems, the tracker provides a user-friendly interface and customizable reports. Choose between a dynamic dashboard or a flat file solution. With IQVIA's expertise, stay ahead of the competition, enhance partnerships, optimize strategies, and make informed decisions. Contact Ken Langenakens at [email protected] to learn more.

Key Updates and Benefits from our Information Offerings

Starting January 2025, our sell-out data services will transition to a new platform, offering faster, more accurate reporting on healthcare product dispensing in Belgium and Luxembourg. This upgrade includes an enhanced pharmacy panel for more reliable data and improved regional coverage.

First Episode: In our first episode, we introduced our vision for delivering fast and accurate reporting on the distribution and dispensing of healthcare products in Belgium and Luxembourg.??

Second Episode: We discussed the evolving landscape of pharmacy panels, focusing on key trends such as increased differentiation in pharmacies and complex distribution patterns. You can watch the video here.?

Third Episode: In our third video we explained how IQVIA is addressing industry challenges through enhanced data collection.??

Stay informed with our ongoing video series, which provides insights into our offerings and industry trends. For personalized support, book a Q&A session or contact us at [email protected].

Transforming Belgium into a Leader in Real-World Data Evidence Generation: 10 Recommendations for a Data-Driven Healthcare System

The American Chamber of Commerce in Belgium (AmCham Belgium) has outlined 10 strategic recommendations to position Belgium as a leader in real-world data (RWD) evidence generation. These focus on creating unique value propositions, securing governmental support, launching awareness campaigns, and establishing legal frameworks to drive Belgium towards a high-quality, data-driven healthcare system. Achieving this vision requires collaboration across government, healthcare providers, industry, and citizens to ensure high standards of quality, innovation, and equity in healthcare.

Key recommendations include:

1. Unique Value Propositions: Highlight the relevance of Belgian healthcare data.
2. Governmental Support: Ensure explicit support for RWD in healthcare decision-making.
3. Awareness Campaigns: Target healthcare practitioners, decision-makers, and the public.
4. Legal Framework: Implement clear regulations for RWD processing.
5. Standardize Data Structures: Improve data accessibility and usability.
6. Innovative Technologies: Invest in technologies to make healthcare data FAIR (Findable, Accessible, Interoperable, and Reusable).
7. Federated Data Networks: Support uniformity and interoperability.
8. International Participation: Engage in global initiatives for enhanced visibility.
9. RWD in Regulatory Decision-Making: Complement traditional methods with RWD.
10. Collaboration and Legal Consensus: Foster collaborative efforts among stakeholders.

THOUGHT LEADERSHIP ROUND-UP

White Paper

Article

Blog

Podcast

Upcoming events

Secondary use of health data: Challenges & Solutions: 17 January 2025, Zaventem. Register here

IQVIA ESG Report

Enjoyed our LinkedIn newsletter? Discover unique insights, new developments, the latest trends and much more in our Customer Newsletter. Don't miss out on staying ahead of the competition - Subscribe Now and receive all the valuable information straight to your inbox.